1Hudson B,Tryggvason K, Sundaramoorthy M, NelisonE. Alport's syndrome, Goodpasture's syndrome ,and type Ⅳ collagen. N Engl J Med ,2003,348:2543-2556.
2Heikkila P,TibellA, Morita T, et al : Adenovirus - mediated transfer type Ⅳ collagen alpha5 chain cDNA into swine kidney in vivo:Deposition of the protein into the glomerular basement membrane. Gene Ther, 2001,8 : 882-890.
3Ricker J, Mata J, Iversen P. Gattone Ⅱ V. c - myc antisense oligo-nucleotide treatment ameliorates murine ARPKD. Kidey Int,2002,61 :S125-S131.
4Carl M, Akagi Y, Weidner S, et al: Specific inhibition of Egr-1 prevents mesangial cell hypercellularity in experimental nephritis. Kidney Int, 2003,63 : 1302-1312.
5Maeshima Y, Kashihara N, Ysuda T,et al. Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo. J Clin Invest, 1998,101:2589-2597.
6Tomita N, Morishita R, Tomita S, et al : Transcription factor decoy for NFkappaB inhibits TNF - alpha - induced cytokine and adhesion molecule expression in vivo. Gene Ther,2000,7 : 1326-1332.
7Terada Y, Tanaka H, Okado T, et al : Ligand - regulatable erythropoietin production by plasmid injection and in vivo electroporation. Kidney Int ,2002,62 : 1966-1976.
8Gao X, Mae H, Ayabe N, et al: Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. Kidney Int ,2002,62 : 1238-1248.
9Yang J, Dai C, Liu Y : Hepatocyte growth factor gene therapy and angiotensin Ⅱ blockade synergistically attenuate renal interstitial fibrosis. J Am Soc Nephrol, 2002,13:2464-2477.
10Shimizu H, Maruyama S, Yuzawa Y, et al.Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria. J Am Soc Nephro1,2003,14 : 1496-1505.
8[4]Bjork lund A,Kirik D,Rosenblad C,et al.Towards aneurop rotective gene therapy for Park in son's disease:use of adenovirus,AAV and lentivrusectors for genetransfer of GDNF to the nro striatalsysteminntherat Park in son ianmodel[J].B rain Res,2000,886:82.
9[8]Tuszynski M H,Smith DE,Roberts J,et al.Targeted in-traparenchymal delivery of human NGF by gentransfer to the primate basalforebrain for 3 months do snotacelerate beta amy-loid plaque deposition[J].Exp N eurol,1998,154:573.
10[11]Davies SW,Turmaine M,Cozens BA.Formation of neuronal intranuclear in clusions underlies the neurological dysfunction in mice transgenic for the HD mutation[J].Cell,1997,90:537-548.
